Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Furoate/Vilanterol vs Fluticasone Propionate in Asthma with Exercise-Induced Bronchoconstriction
NCT01435902Phase 3Withdrawn
- Sponsor
- GSK
- Start
- Jan 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fluticasone furoate + vilanterol in asthma, sponsored by GSK. Planned start Jan 2012; status: withdrawn.
02
Drugs
fluticasone furoate + vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01435902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01435902.